US Patent 9968676 Subcutaneous anti-HER2 antibody formulations and uses thereof
Patent 9968676 was granted and assigned to Genentech on May, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 25, 2016
Date of Patent
May 15, 2018
Patent Applicant
Patent Application Number
15053217
Patent Citations Received
Patent Inventor Names
Hanns-Christian Mahler
0
Oliver Boris Stauch
0
Ulla Grauschopf
0
Michael Adler
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9968676 Subcutaneous anti-HER2 antibody formulations and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.